Detail of the hippocampus of control subjects (left) and with Down syndrome (right) where the CBR1 receptor is observed in brown and the nuclei of neurons in lilac. In 2019, a research group led by ...
Hosted on MSN
Long-term pharmacological treatment shows promise against memory impairments in Down syndrome
In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, described that mice models for Down syndrome have more cannabinoid receptor ...
A study in mouse models and human tissue, carried out by researchers at the Barcelona Institute of Science and Technology Centre for Genomic Regulation (CRG), has found that the small nuceleolar RNA ...
The activity of Snhg11, a gene found in the 'dark matter' of the genome, is critical for the function and formation of neurons in the hippocampus, specifically in an area critical for learning and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results